p53 and p63 Proteoforms Derived from Alternative Splicing Possess Differential Seroreactivity in Colorectal Cancer with Distinct Diagnostic Ability from the Canonical ProteinsAna Montero‐Calle, Rodrigo Barderas, Víctor Ruiz‐Valdepeñas Montiel et al.|Cancers|2023Cited by 23
Reprogramming CD8+ T-cell Branched <i>N-</i> Glycosylation Limits Exhaustion, Enhancing Cytotoxicity and Tumor KillingCatarina M. Azevedo, Salomé S. Pinho, Carolina S. Dantas et al.|Cancer Immunology Research|2025Cited by 4
Data from Reprogramming CD8<sup>+</sup> T-cell Branched <i>N-</i>Glycosylation Limits Exhaustion, Enhancing Cytotoxicity and Tumor KillingCatarina M. Azevedo, Salomé S. Pinho, Bingxian Xie et al.|Unknown|2025Cited by 1
Figure S3 from Reprogramming CD8<sup>+</sup> T-cell Branched <i>N-</i>Glycosylation Limits Exhaustion, Enhancing Cytotoxicity and Tumor KillingCatarina M. Azevedo, Salomé S. Pinho, Bingxian Xie et al.|Unknown|2025Cited by 0
Table S1 from Reprogramming CD8<sup>+</sup> T-cell Branched <i>N-</i>Glycosylation Limits Exhaustion, Enhancing Cytotoxicity and Tumor KillingCatarina M. Azevedo, Salomé S. Pinho, Bingxian Xie et al.|Unknown|2025Cited by 0